EZH2 and neoplasm: Together, the EZH2 and KDM6A reports raise the possibility that H3K27 demethylation may underlie a female-biased tumor suppressor phenotype, while EZH2 and PRC2 activity may underlie a male-biased oncogenic phenotype (Figure 3).